Stay updated with breaking news from Boris Kantor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At AAIC, researchers presented studies using CRISPR-Cas9 in animal/organoid models of Alzheimer’s disease, but some experts doubt that such approaches will successfully translate to humans.
Two new studies using CRISPR gene editing offer potential new treatments for Alzheimer's disease.
The research on using CRISPR against Alzheimer's is in its infancy, with results reported just from mice and lab-made mini-brains.
Key Takeaways:Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments.One seeks to dampen the impact of the most com...
/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central...